Please login to the form below

Not currently logged in
Email:
Password:

GSK's Lawson elected PAGB president

He will help lead OTC trade body after departure of Novartis' David Barnett
pagb Carlton Lawson

The Proprietary Association of Great Britain (PAGB), which represents OTC companies in the UK, has elected Carlton Lawson of GlaxoSmithKline (GSK) as its new president.

On March 3 Lawson, who is general manager of GSK's consumer health business in the UK and Ireland, will take over from Novartis' David Barnett who moves to a new position in Latin America.

Lawson was only appointed to his current GSK position last year having previously served as global business lead in oral heath at the healthcare giant.

This followed a career that included senior sales and brand roles at Warner Lamber, Pfizer and Johnson & Johnson. He has experience with the PAGB too, being elected vice president in 2007.

Matthew Speers, chief executive of the PAGB, said he was “looking forward to working with Lawson”.

“Having served on the PAGB board previously when he was general manager at Johnson & Johnson, he has in-depth knowledge of PAGB and this past experience will be a great asset in helping drive forward PAGB's work programme, particularly the better regulation agenda,” said Speers.

26th February 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics